Transcatheter atrial septal defects and patent foramen ovale closure: Medicare utilization and reimbursements

Table 1 The annual number of services, charges, and payments, along with the inflation-adjusted average rate of reimbursement per procedure and the average annual growth rate of the procedure, is depicted below

Year	Procedure/services	Charges	Payment	Inflation adjusted average rate	Annual growth rate of reimbursement1	Annual growth rate of procedures2
2022	2455	$2319536.28	$1818140.15	$770.21	-46.56	81.05
2021	2449	$2333765.36	$1860376.25	$835.61	-25.97	80.61
2020	2168	$2130582.64	$1693305.75	$890.39	-21.12	59.88
2019	2590	$2564044.60	$2010862.74	$908.38	-19.53	91.00
2018	2260	$2225464.21	$1725140.80	$923.64	-18.17	66.67
2017	1697	$1672085.09	$1293973.58	$953.13	-15.56	25.15
2016	1475	$1435750.68	$1112748.71	$995.82	-11.78	8.77
2015	1311	$1286539.46	$1000438.04	$1045.46	-7.38	-3.32
2014	1251	$1233624.63	$952857.12	$1142.51	1.21	-7.74
2013	1356	$1312737.26	$1020439.87	$1128.81

¹Depicts annual percentage change in reimbursements per case for transcatheter atrial septal defect/patent foramen ovale closure procedures.

²Depicts annual percentage change in transcatheter atrial septal defect/patent foramen ovale closure procedures. P value < 0.01 after linear regression analysis.